Ohsugi T, Maejima K, Urano T
Laboratory Animals Breeding Facilities, Osaka University Medical School, Japan.
Microbiol Immunol. 1991;35(9):789-94. doi: 10.1111/j.1348-0421.1991.tb01611.x.
Bacterial translocation from the gastrointestinal (GI) tract to other internal organs was examined in multiple low-dose streptozotocin-injected (M-STZ), single large-dose streptozotocin-injected (S-STZ), alloxan-injected (Alloxan), and non-obese diabetic (NOD) mice. The incidence of bacterial translocation from the GI tract to the tested organs among diabetic mice was in the order of M-STZ mice greater than S-STZ mice greater than NOD, Alloxan, and control mice. The injections of insulin to M-STZ mice did not decrease the incidence of translocation. These results suggest that bacterial translocation from the GI tract in diabetic mice is not induced by diabetes.
在多次注射低剂量链脲佐菌素(M-STZ)、单次注射大剂量链脲佐菌素(S-STZ)、注射四氧嘧啶(Alloxan)以及非肥胖糖尿病(NOD)小鼠中,检测了细菌从胃肠道(GI)转移至其他内部器官的情况。糖尿病小鼠中,细菌从胃肠道转移至受试器官的发生率依次为:M-STZ小鼠大于S-STZ小鼠大于NOD、Alloxan小鼠以及对照小鼠。给M-STZ小鼠注射胰岛素并未降低转移发生率。这些结果表明,糖尿病小鼠胃肠道的细菌转移并非由糖尿病诱导。